Abiomed

heart model with cardiologist
MedTech

J&J delivers 10-year Impella gains in severe heart attacks

Johnson & Johnson MedTech demonstrated that its Impella CP can help STEMI heart attack patients gain an additional 600 days of life, on average.
Conor Hale Sep 2, 2025 1:30pm
FDA

FDA opens use of J&J's Impella heart pumps to pediatric patients

Dec 12, 2024 2:30pm
Pink Porcelain Anatomical Heart - stock photo Paul CampbellGetty Images

TCT: Abiomed clears pivotal study for shrinkable heart pump

Oct 30, 2024 9:00am
Johnson Johnson

J&J CEO says M&A strategy to 'continue' after medtech megadeals

Apr 16, 2024 1:42pm
heart model

J&J's Abiomed pump reduces deaths after widowmaker heart attacks

Apr 8, 2024 12:12pm
Pink Porcelain Anatomical Heart - stock photo Paul CampbellGetty Images

J&J's Abiomed sees serious Impella recall linked to 49 deaths

Mar 21, 2024 2:29pm